Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M112,750Revenue $M42,750Net Margin (%)17.6Z-Score2.2
Enterprise Value $M137,661EPS $1.8Operating Margin %22.5F-Score6
P/E(ttm))17.3Cash Flow Per Share $0Pre-tax Margin (%)21.0Higher ROA y-yY
Price/Book14.110-y EBITDA Growth Rate %3.1Quick Ratio0.7Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %2.5Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-22.6ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %5.6Insider Buy (3m)0ROE % (ttm)68.0Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M4,804ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

GLAXF is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29343.67 view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1295.58 view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1467.64 view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1295.58 view

Press Releases about GLAXF :

    Quarterly/Annual Reports about GLAXF:

      News about GLAXF:

      Articles On GuruFocus.com
      Jeff Auxier Buys Berkshire Hathaway in Third Quarter Nov 18 2014 
      Irving Kahn Starts New Position In GlaxoSmithKline Nov 13 2014 
      Irving Kahn Buys Stake in GlaxoSmithKline During Q3 2014 Nov 12 2014 
      Kahn Brothers' Third Quarter Numbers Nov 07 2014 
      Tweedy Browne Global Value Fund's Top Picks for Q3 Oct 21 2014 
      Diamond Hill Capital Comments on GlaxoSmithKline PLC Oct 17 2014 
      Dodge & Cox’ Stock Fund Third Quarter 2014 Commentary Oct 16 2014 
      Ebola: Is The Cure Out There? Oct 14 2014 
      Guru Stocks at 52-Week Lows: GE, BHP, TOT, BP, GSK Oct 12 2014 
      Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF Sep 30 2014 

      More From Other Websites
      Cuban doctor to be flown to Geneva for Ebola care - Swiss Nov 19 2014
      Reckitt Benckiser shareholders should sell new pharma shares Nov 18 2014
      AstraZeneca lupus drug produces positive results in trial Nov 17 2014
      No safety concerns yet in trials of GSK's Ebola vaccine Nov 17 2014
      GlaxoSmithKline leads Access to Medicine Index Nov 16 2014
      Bristol-Myers Squibb to build Irish biologics facility Nov 14 2014
      US private equity outfit to bid for GlaxoSmithKline´s mature drugs business Nov 13 2014
      Unanswered questions in Tesco’s accounting scandal Nov 06 2014
      The unanswered questions in Tesco’s accounting scandal Nov 06 2014
      GSK hepatitis C shot shows promise, bodes well for Ebola vaccines Nov 05 2014
      Regus forecasts capex below estimates, eases fears over debt Oct 31 2014
      Tesco Faces Criminal Probe Over Profits Crisis Oct 29 2014
      SFO Launches Criminal Probe Into Tesco Crisis Oct 29 2014
      Swiss test GSK Ebola vaccine in some volunteers going to Africa Oct 28 2014
      GSK Nigeria 9-month pre-tax profit falls 25.9 pct Oct 28 2014
      GSK shareholder-friendly policy shift could hurt credit profile, Fitch says Oct 27 2014
      WHO vaccines boss signs up as Ebola trial guinea pig Oct 24 2014
      U.S. tightens Ebola monitoring for West African visitors Oct 22 2014
      GLOBAL MARKETS-Shares falter as Wall St tumbles; bond prices fall Oct 22 2014
      GLOBAL MARKETS-Shares falter as Wall St tumbles, bond prices fall Oct 22 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK